Friday, May 14th | 3 Sivan 5781

Subscribe
April 29, 2021 9:12 am
0

Israel Data Shows Pfizer Vaccine 97 Percent Effective Against British Variant

avatar by JNS.org

A vial of the Pfizer vaccine against the coronavirus disease (COVID-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel December 19, 2020. Picture taken December 19, 2020. REUTERS/Amir Cohen

JNS.org – Israeli medical data has shown that the Pfizer BioNTech vaccine is 97 percent effective against the British variant of the coronavirus, the founder of BioNTech said on Wednesday.

Dr. Ugur Sahin, the co-founder of BioNTech, who helped develop the vaccine, told Israel’s Kan News public broadcaster that the company is currently examining the vaccine’s efficiency against the Indian variant.

Sahin praised Israel’s vaccine deployment, calling the organization of the mass vaccination program “simply perfect” during his interview.

He noted that recent meetings held by the pharmaceutical company have involved an analysis of Israeli data, allowing it to calculate how many lives the vaccine saved in the past four months.

Related coverage

May 14, 2021 10:03 am

Israeli Fashion Startup Zeekit Acquired by Walmart

JNS.org - Walmart, the world's largest retailer, is acquiring Israeli fashion startup Zeekit for an undisclosed sum. Founded in 2013...

In separate comments, Sahin said “we are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident,” according to AFP.

Also on Wednesday, Deputy Health Minister Yoav Kish said during a Knesset plenary session that Israel will likely remove its last remaining internal coronavirus restrictions, known as the “Green Pass,” next month if infection rates continue to drop and remain very low, according to Maariv.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.